Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity
Author(s)
Sorek, Matan; Oweis, Walaa; Nissim-Rafinia, Malka; Maman, Moria; Simon, Shahar; Hession, Cynthia C.; Adiconis, Xian; Simmons, Sean K.; Sanjana, Neville E.; Shi, Xi; Lu, Congyi; ... Show more Show less
Download13059_2021_Article_2301.pdf (2.533Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Abstract
Background
Many neurodegenerative diseases develop only later in life, when cells in the nervous system lose their structure or function. In many forms of neurodegenerative diseases, this late-onset phenomenon remains largely unexplained.
Results
Analyzing single-cell RNA sequencing from Alzheimer’s disease (AD) and Huntington’s disease (HD) patients, we find increased transcriptional heterogeneity in disease-state neurons. We hypothesize that transcriptional heterogeneity precedes neurodegenerative disease pathologies. To test this idea experimentally, we use juvenile forms (72Q; 180Q) of HD iPSCs, differentiate them into committed neuronal progenitors, and obtain single-cell expression profiles. We show a global increase in gene expression variability in HD. Autophagy genes become more stable, while energy and actin-related genes become more variable in the mutant cells. Knocking down several differentially variable genes results in increased aggregate formation, a pathology associated with HD. We further validate the increased transcriptional heterogeneity in CHD8+/− cells, a model for autism spectrum disorder.
Conclusions
Overall, our results suggest that although neurodegenerative diseases develop over time, transcriptional regulation imbalance is present already at very early developmental stages. Therefore, an intervention aimed at this early phenotype may be of high diagnostic value.
Date issued
2021-03-04Department
Massachusetts Institute of Technology. Department of Chemical Engineering; Koch Institute for Integrative Cancer Research at MIT; Massachusetts Institute of Technology. Department of Biological EngineeringPublisher
BioMed Central
Citation
Genome Biology. 2021 Mar 04;22(1):73
Version: Final published version